Sudden Cardiac Death in Heart Failure Trial - SCD-HeFT

Description:

The goal of the trial was to evaluate the effectiveness of amiodarone therapy or an implantable cardioverter defibrillator (ICD) with placebo in patients with New York Heart Association (NYHA) class II and III congestive heart failure (CHF) and reduced left ventricular ejection fraction (LVEF) ≤35%.